-+ 0.00%
-+ 0.00%
-+ 0.00%

Incannex Healthcare Board Authorizes Share Repurchase Program For Up To $20M

Benzinga·08/22/2025 12:02:24
Listen to the news

Incannex Healthcare Inc. (NASDAQ:IXHL) ("Incannex" or the "Company"), a clinical-stage biopharmaceutical company developing innovative combination therapies for high-impact conditions, today announced that its Board of Directors has authorized a share repurchase program (the "Repurchase Program") for up to $20 million of the Company's outstanding shares of common stock ("Common Stock").

Under the Repurchase Program, the Company may repurchase shares of Common Stock through open market purchases, privately negotiated transactions, accelerated share repurchase arrangements, or other methods permitted under applicable securities laws, including under Rule 10b5-1 trading plans and in compliance with Rule 10b-18 of the Securities Exchange Act of 1934, as amended.

The Repurchase Program reflects Incannex's commitment to driving sustainable shareholder value while maintaining discipline in capital allocation to support the advancement of its late-stage clinical pipeline.